CORAL LAB. share price has zoomed 5% and is presently trading at Rs 866.0.
Meanwhile, the BSE HEALTHCARE index is at 43,973.8 (up 0.3%).
Among the top gainers in the BSE HEALTHCARE index today are Procter & Gamble Health (up 6.6%) and GLAND PHARMA (up 3.4%).
FORTIS HEALTHCARE (down 2.4%) and MAX HEALTHCARE INSTITUTE (down 1.9%) are among the top losers today.
Over the last one year, CORAL LAB. has moved up from Rs 280.9 to Rs 866.0, registering a gain of Rs 585.1 (up 208.3%).
On the other hand, the BSE HEALTHCARE index has moved up from 27,350.0 to 43,973.8, registering a gain of 60.8% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 229.2%), SUVEN PHARMACEUTICALS (up 130.2%) and Glenmark Pharma (up 129.8%).
Don't Miss: Key Information for Long-term Investors
The BSE Sensex is at 78,791.1 .
The top gainers among the BSE Sensex today are JSW Steel (up 1.9%) and Tata Steel (up 1.6%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.
In the meantime, NSE Nifty is at 23,983.7 (down 0.1%). Coal India and MUNDRA PORT & SEZ are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 63,591.3 to 78,791.1, registering a gain of 15,199.8 points (up 23.9%).
CORAL LAB. net profit grew 378.0% YoY to Rs 88 million for the quarter ended June 2024, compared to a profit of Rs 18 million a year ago. Net sales rose 133.7% to Rs 317 million during the period as against Rs 135 million in April-June 2023.
For the year ended March 2024, CORAL LAB. reported 145.0% increase in net profit to Rs 158 million compared to net profit of Rs 64 million during FY23. Revenue of the company grew 7.1% to Rs 837 million during FY24.
The current Price to earnings ratio of CORAL LAB., based on rolling 12 month earnings, stands at 13.6.
Equitymaster requests your view! Post a comment on "CORAL LAB. Gains 5%; BSE HEALTHCARE Index Up 0.3%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!